fda compounding semaglutide warning letters news issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of February 17, 2026: Pennsylvania compounding

Enjoy a non-invasive, daily dose solution without injections for convenient weight management.

Keeping weight off after GLP-1 drugs

Several potential interventions can induce autophagy in ...

Novo Nordisk, the manufacturer of Ozempic and Wegovy, has petitioned the Food and Drug Administration (FDA) to add semaglutide, the active ingredient in Wegovy and Ozempic, to the "Demonstrable Difficulties for Compounding" list, which would effectively ban compounding pharmacies from producing compounded versions of these medications

Switching from Zepbound to Ozempic is possible, but they have different active ingredients and FDA-approved uses, and they work in different ways.

Explore Injectable Sermorelin, a peptide therapy designed to support healthy growth hormone production, recovery, restful sleep, and healthy aging